Media Coverage
The work done by Northwestern University Feinberg School of Medicine faculty members (and even some students) is regularly highlighted in newspapers, online media outlets and more. Below you’ll find links to articles and videos of Feinberg in the news.
-
TODAY
–
What’s the safest vacation to take? Experts answer 14 burning questions
TODAY spoke with Mercedes Carnethon, professor and vice chair of preventive medicine at the Northwestern University Feinberg School of Medicine, and Linsey Marr, professor of civil and environmental engineering at Virginia Tech who also has expertise in the airborne transmission of viruses, about the best practices for travel during the pandemic.
-
Chicago Tribune
–
Northwestern seeks 5,000 volunteers to participate in COVID-19 vaccine trials
“We are casting a really wide net so we can make sure we have enough people identified and ready to go for upcoming studies,” said Dr. Karen Krueger, principal investigator of the registry and Northwestern Medicine physician and instructor. “This is vital to individuals’ and community health during the coronavirus pandemic.”
-
The Washington Post
–
Confused by CDC’s changing guidance on school reopening? Here are recommendations from experts not pressured by the White House.
The two are Wendy Armstrong, professor of medicine in the Division of Infectious Diseases at Emory University’s School of Medicine, and Tina Tan, professor of pediatrics in the Division of Infectious Diseases at Northwestern University’s Feinberg School of Medicine. Both are board members of the Infectious Disease Society of America.
-
Chicago Tribune
–
Elementary schools may be safer to reopen, doctors say
Should schools reopen, said Tina Tan, an IDSA board member and pediatrics professor at Northwestern University’s Feinberg School of Medicine, there is no way to know which children are most vulnerable to getting COVID-19, or the mysterious related illness impacting some more severely, including some in Illinois.
-
USA Today
–
Uncounted millions had COVID-19 symptoms, but no positive test
“Most cases are not going to lead to outbreaks or super-spreading events, but some are. And you don’t really know which ones those are going to be,” said Jaline Gerardin, an assistant professor of preventive medicine at Northwestern University’s Feinberg School of Medicine. “They can be devastating. They can restart your outbreak.”
-
Chicago Tribune
–
What is herd immunity? And how do we get there on COVID-19?
But epidemiologists and other public health experts say that’s a really lousy idea. “It’ll kill millions of people,” said Dr. Robert Murphy, executive director of the Institute for Global Health at the Northwestern University Feinberg School of Medicine. “Millions of people will die.” So, what is herd immunity? Is it a good thing? And, if it is, what’s the best way to achieve it?
-
TODAY
–
Why racism can have long-term effects on children’s health
Dr. Nia Heard-Garris was startled when her 4-year-old son came home from preschool one day and declared, “Mommy, sometimes I’m white.” As a pediatrician who studies the impact of racism on children’s health and the mother of a Black boy with caramel skin, she carefully inquired further. He told her one of his friends said he only played with white kids.
-
The New York Times
–
Ginsburg Says Her Cancer Has Returned, but She’s ‘Fully Able’ to Remain on Court
Doctors not involved in her care said there were various ways to treat cancer that has spread to the liver. “We’re pretty good at controlling it with chemotherapy and targeted therapy,” said Dr. Christopher George, a medical oncologist at Northwestern Medicine in Chicago.
-
CBS News
–
Remdesivir shortages force doctors to make “heart-wrenching” choices
“We need a fair and transparent process,” tweeted Michael Ison, an infectious disease physician at Northwestern University’s School of Medicine in Chicago, who referenced the “chaos” about the distribution of remdesivir.
-
The Washington Post
–
Long delays in getting test results hobble coronavirus response
Jaline Gerardin, an expert in disease modeling at Northwestern University, said she believes that “nationally, we’d likely save tens of thousands of lives” if test turnaround times were shortened. In the absence of a coordinated federal response, Harvard’s Jha said, states should band together — in European Union-like blocs — to solve supply problems.
